α-lipoic acid promotes the growth of rat hepatic pre-neoplastic lesions in the choline-deficient model

Carcinogenesis

Volumn 29, Issue 1, 2008, Pages 161-168

  Perra, Andrea ^a   Pibiri, Monica ^a   Sulas, Pia ^a   Simbula, Gabriella ^a   Ledda Columbano, Giovanna Maria ^a   Columbano, Amedeo ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINE; CYCLOOXYGENASE 2; CYTOCHROME P450 2E1; DIETHYLNITROSAMINE; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE TRANSFERASE; STAT3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; THIOCTIC ACID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DIET THERAPY; ENZYME ACTIVATION; HISTOPATHOLOGY; LIPID PEROXIDATION; LIPID STORAGE; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER INJURY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIOXIDANTS; CELL DEATH; CHOLINE DEFICIENCY; LIPID PEROXIDATION; LIVER NEOPLASMS; PRECANCEROUS CONDITIONS; RATS; THIOCTIC ACID;

EID: 38849181533     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgm205     Document Type: Article

References (50)

1. Llovet,J.M. et al. (2003) Hepatocellular carcinoma. Lancet, 362, 1907-1917.
2. Thorgeirsson,S.S. et al. (2006) Functional genomics of hepatocellular carcinoma, Hepatology, 43, S145-S150.
3. Biewenga,G.P. et al. (1997) The pharmacology of the antioxidant lipoic acid. Gen. Pharmacol., 29, 315-331.
4. Roy,S. et al. (1998) Redox regulation of cell functions by α-lipoate: Biochemical and molecular aspects. Biofactors, 7 263-267.
5. Ziegler,D.M. et al. (1995) Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant α-lipolic acid: A 3-week multicentre randomized controlled trial (ALADIN study). Diabetologia 38, 1425-1433.
6. El Midaoui,A. et al. (2002) Prevention of hypertension, insulin resistance, and oxidative stress by α-lipoic acid. Hypertension, 39, 303-307.
7. Ha,H. et al. (2006) α-lipoic acid inhibits inflammatory bone resorption by suppressing prostaglandin E2 synthesis. J. Immunol., 176, 111-117.
8. Bludovska,M. et al. (1999) The influence of α-lipoic acid on the toxicity of cadmium. Gen. Physiol. Biophys., 18, 28-32.
9. Bustamante,J. et al. (1998) α-lipoic acid in liver metabolism and disease. Free Radic. Biol. Med., 24, 1023-1039.
10. Marley,R. et al. (1999) Lipoic acid prevents development of hyperdynamic circulation in anesthetized rats with biliary cirrhosis. Hepatology, 29, 1358-1363.
11. Mantovani,G. et al. (2003) The impact of different antioxidant agents alone or in combination on reactive oxygen species, antioxidant enzymes and cytokines in a series of advanced cancer patients at different sites: Correlatiog with disease progression. Free Radic. Res., 37, 213-223.
12. 2 generation. Apoptosis, 10, 359-368.
13. Sen,C.K. et al. (1999) Fas mediated apoptosis of human Jurkat T-cells: Intracellular events and potentiation by redox-active alpha-lipoic acid. Cell Death Differ., 6, 481-491.
14. kip1-dependent cell cycle arrest in non transformed cell lines and apoptosis in tumor cell lines. J. Cell. Physiol., 194, 325-340.
15. Simbula,G. et al. (2007) Increased ROS generation and p53 activation in α-lipoic acid-induced apoptosis of hepatoma cells. Apoptosis, 12, 113-123.
16. Goldsworthy,T.L. et al. (1986) Models of hepatocarcinogenesis in the rat - contrasts and comparisons. CRC Crit. Rev. Toxicol., 17, 61-89.
17. Farber,E. et al. (1980) The sequential analysis of cancer development. Adv. Cancer Res., 31, 125-226.
18. Ito,N. et al. (1988) Enhancing effect of various hepatocarcinogens on induction of preneoplastic glutathione S-transferase placental form positive foci in rats - an approach for a new medium term bioassay system. Carcinogenesis, 9, 387-394.
19. Shinozuka,H. et al. (1985) Pathology of choline deficiency. In Sidransky,H. (ed.) Nutritional Pathology. Marcel Dekker, New York, pp. 279-320.
20. Newberne,P.M. (1986) Lipotropic factors and oncogenesis. Adv. Exp. Med. Biol., 206, 23-151.
21. Takahashi,S. et al. (1982), Progression of carcinogen-induced foci of gamma-glutamyltranspeptidase-positive hepatocytes to hepatoma in rats fed a choline-deficient diet. Int. J. Cancer, 29, 445-450.
22. Newberne,P.M. et al. (1988) Dietary modifiers of cancer. Prog. Clin. Biol. Res., 258, 105-129.
23. Flier,J.S et al. (1993) The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N. Engl. J. Med., 328, 1828-1835.
24. Tatematsu,M. et al. (1988) Stable phenotypic expression of glutathione S-transferase placental type and unstable phenotypic expression of gamma-glutamyltransferase in rat liver preneoplastic and neoplastic lesions. Carcinogenesis, 9, 215-220.
25. Pitot,H.C. et al. (1991) Biochemical markers associated with the stages of promotion and progression during hepatocarcinogenesis in the rat. Environ. Health Perspect., 93, 181-189.
26. Ledda-Columbano,G.M. et al. (2000) Cell proliferation induced by triiodothyronine in rat liver is associated with nodule regression and reduction of hepatocellular carcinoma. Cancer Res., 60, 603-609.
27. Chander,N. et al. (1987) Liver cell turnover in rats fed a choline-devoid diet. Carcinogenesis, 8, 669-673.
28. Abramoff,M.D. et al. (2004) Image processing with imagej. Biophotonics Int., 11, 36-42.
29. Ledda-Columbano,G.M. et al. (2005) Induction of acinar cell proliferation by thyroid hormone. J. Endocrinol., 185, 393-399.
30. Esterbauer,H. et al. (2000) Determination of aldehydic lipid peroxidation products: Malondialdehyde and 4-hydroxynonenal. Methods Enzymol., 186, 407-421.
31. Columbano,A. et al. (2006) The thyroid hormone receptor-β agonist GC-1 induces cell proliferation in rat liver and pancreas. Endocrinology, 147, 3211-3218.
32. Hagen,T.M. et al. (1999) (R)-α-lipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate. FASEB J., 13, 411-418.
33. Reddy,J.K. et al. (2005) Lipid metabolism and liver inflammatio. II. Fatty liver disease and fatty acid oxidation: Am. J. Physiol. Gastrointest. Liver Physiol., GI290, 852-858.
34. Nakae,D. et al. (1990) Production of both 8-hydroxydeoxyguanosine in liver DNA and γ-glutamyltransferase-positive hepatocellular lesions in rats given a choline deficient, L-amino acid defined diet. Jpn. J. Cancer Res., 81, 1081-1085.
35. Tsutsumi,M. et al. (1994) Genetic polymorphism of cytochrome P4502E1 related to the development of alcoholic liver disease. Gastroenterology, 107, 1430-1435.
36. Weltman,M.D. et al. (1998) Hepatic cytochrome P450 2E1 is increased in patients with non-alcoholic steatohepatitis. Hepatology, 27, 128-133.
37. Sanyal,A.J. et al. (2001) Non-alcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology, 120, 1183-1192.
38. Weltman,M.D. et al. (1996) Increased. Cyp2E1 expression in a rat model of hepatic steatosis with inflammation. Gastroenterology, 111, 1645-1653.
39. Yu,J. et al. (2006) COX-2 induction in mice with experimental nutritional steatohepatitis: Role as pro-inflammatory mediator. Hepatology, 43, 826-836.
40. Liu,H. et al. (2002) Increased cytochrome P-450 2E1 expression sensitises hepatocytes to c-jun mediated cell death from TNF-alpha. Am J. Physiol. Gastrointest. Liver Physiol., 282, G257-G266.
41. Levy,D.E. et al. (2002) What does Stat3 do? J. Clin. Invest. 109, 1143-1148.
42. Mudter,J. et al. (2005) Activation pattern of signal transducers and activators of transcription (STAT) factors in inflammatory bowel diseases. Am. J. Gastroenterol., 100, 64-72.
43. Han,X. et al. (2005) Growth hormone inhibits signal transducer and activator of transcription 3 activation and reduces disease activity in murine colitis. Gastroenterology, 129, 185-203.
44. Columbano,A. et al. (1981) Requirement of cell proliferation for the initiation of liver carcinogenesis as assayed by three different procedures. Cancer Res., 41, 2079-2083.
45. Pound,A.W. et al. (1978) Repeated partial hepatectomies as a promoting stimulus for carcinogenic response of liver to nitrosamines in rats. Br. J. Cancer., 371, 585-594.
46. Dragani,T.A. et al. (1986) Enhancing effect of carbon tetrachloride in mouse hepatocarcinogenesis. Cancer Lett., 31 171-179.
47. Takahashi,T. et al. (1993) Induction of cytochrome P-4502E1 in the human liver by ethanol is caused by a corresponding increase in encoding messenger RNA. Hepatology, 17, 236-245.
48. George,J. et al. (1995) Differential alterations of cytochrome P450 proteins in livers from patients with severe chronic liver disease. Hepatology, 21, 120-128.
49. Cressman,D.E. et al. (1996) Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science, 274, 1379-1383.
50. Yamada,Y. et al. (1997) Initiation of liver growth by tumor necrosis factor: Deficient liver regeneration in mice lakcing type I tumor necrosis factor receptor. Proc. Natl Acad. Sci. USA., 94 1441-1446.